8 results
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Disease Initial ... disease (COPD) ... and exacerbation risk ... #Algorithm #Management ... #Pulmonary #LABA
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment algorithms ... Obstructive Lung Disease ... #Management #Pulmonary ... #COPD #GOLD2017 ... #LAMA #LABA #ICS
Atrial Fibrillation (A-Fib) Summary

Symptoms:
• Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope.

Why?
Cardiac:
	• Valvular heart
Decompensated HF ... Noncardiac: • Pulmonary ... cardiovascular risk ... level (if patient is ... #diagnosis #management
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
murmur 3/6) - Pulmonary ... b) CHF c) ... event, follow ACC algorithm ... Determine if any labs ... medical and surgical management
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Attempt if high risk ... Diagnosis: • Labs ... Imaging: CXR- pulmonary ... sepsis), PE, DAH, CHF ... APML #diagnosis #management
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Valvular heart disease ... Congenital heart disease ... cardiomyopathy • Pulmonary ... May have typical HF ... Serial TTE and close
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... lab markers such ... #differential #algorithm ... #management #cardiology ... #heartfailure #chf
Mycoses

HISTOPLASMOSIS
• Inhalation of conidia → Yeast → travel to lymph nodes → spread in body
• Bird
MUCORMYCOSIS • Risk ... Diagnosis: • Labs ... Encapsulated yeast • At risk ... MC: CNS CSF: • ... Fungal #Diagnosis #Management